The FOXO3a Transcription Factor Regulates Cardiac Myocyte Size Downstream of AKT Signaling*
暂无分享,去创建一个
A. Goldberg | I. Shiojima | M. Sandri | K. Walsh | C. Skurk | Y. Izumiya | H. Maatz | P. Razeghi | Kaori Sato | Ling Zeng | S. Schiekofer | D. Pimentel | S. Lecker | H. Taegtmeyer | Yasuhiro Izumiya
[1] A Celentano,et al. Cardiac abnormalities in young women with anorexia nervosa. , 1994, British heart journal.
[2] G. Thomas,et al. TOR signalling and control of cell growth. , 1997, Current opinion in cell biology.
[3] M. Birnbaum,et al. Regulation of Angiogenesis by Glycogen Synthase Kinase-3β* , 2002, The Journal of Biological Chemistry.
[4] Hiroyuki Aburatani,et al. Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control*[boxs] , 2004, Journal of Biological Chemistry.
[5] J. Papadimitriou,et al. Regression of Left Ventricular Dilation and Hypertrophy after Removal of Volume Overload: Morphological and Ultrastructural Study , 1974, Circulation research.
[6] Yi-Ping Li,et al. Atrophic Remodeling of the Heart In Vivo Simultaneously Activates Pathways of Protein Synthesis and Degradation , 2003, Circulation.
[7] G. Yancopoulos,et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.
[8] A. Goldberg,et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[9] Stephen J. Elledge,et al. SKP1 Connects Cell Cycle Regulators to the Ubiquitin Proteolysis Machinery through a Novel Motif, the F-Box , 1996, Cell.
[10] P. Kang,et al. Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] P. Hasselgren,et al. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. , 2003, The international journal of biochemistry & cell biology.
[12] R. Zhao,et al. Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity , 2005, Oncogene.
[13] A. Hoeflich,et al. IGF-binding protein-5: flexible player in the IGF system and effector on its own. , 2002, The Journal of endocrinology.
[14] W. Cavenee,et al. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. , 1998, Genomics.
[15] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[16] G. Shipley,et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy , 1998, Nature Medicine.
[17] D. Cyr,et al. CHIP Is a U-box-dependent E3 Ubiquitin Ligase , 2001, The Journal of Biological Chemistry.
[18] P A Lachenbruch,et al. Quantitative Changes in the Capillary Bed during Developing, Peak, and Stabilized Cardiac Hypertrophy in the Spontaneously Hypertensive Rat , 1982, Circulation research.
[19] I. Shiojima,et al. Akt Activity Negatively Regulates Phosphorylation of AMP-activated Protein Kinase in the Heart* , 2003, Journal of Biological Chemistry.
[20] G. Fishman,et al. Conditional transgene expression in the heart. , 1996, Circulation research.
[21] R. Kitsis,et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. , 2000, Circulation.
[22] S. Cook,et al. Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart* , 2002, The Journal of Biological Chemistry.
[23] J. Testa,et al. Cell Cycle Withdrawal Promotes Myogenic Induction of Akt, a Positive Modulator of Myocyte Survival , 1999, Molecular and Cellular Biology.
[24] Marco Sandri,et al. Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.
[25] C. Kahn,et al. Regulation of Myocardial Contractility and Cell Size by Distinct PI3K-PTEN Signaling Pathways , 2002, Cell.
[26] K. Chien,et al. Signaling pathways for cardiac hypertrophy and failure. , 1999, The New England journal of medicine.
[27] W. Aird,et al. The Akt-regulated Forkhead Transcription Factor FOXO3a Controls Endothelial Cell Viability through Modulation of the Caspase-8 Inhibitor FLIP* , 2004, Journal of Biological Chemistry.
[28] M. Greenberg,et al. Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.
[29] A. Banes,et al. A new vacuum-operated stress-providing instrument that applies static or variable duration cyclic tension or compression to cells in vitro. , 1985, Journal of cell science.
[30] J. Balligand,et al. Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes , 2001, Nature Cell Biology.
[31] S. Kihara,et al. Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.
[32] M. Nieminen,et al. Prognostic significance of left ventricular mass change during treatment of hypertension. , 2004, JAMA.
[33] K. Nakayama,et al. U Box Proteins as a New Family of Ubiquitin-Protein Ligases* , 2001, The Journal of Biological Chemistry.
[34] Jian Xu,et al. Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy , 2004, Circulation research.
[35] A. Goldberg,et al. Patterns of gene expression in atrophying skeletal muscles: response to food deprivation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] A. Kuroiwa,et al. Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects. , 1996, American heart journal.
[37] D. Levy,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.
[38] D. Accili,et al. FoxOs at the Crossroads of Cellular Metabolism, Differentiation, and Transformation , 2004, Cell.
[39] M. Birnbaum,et al. Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice* , 2001, The Journal of Biological Chemistry.
[40] L. Kirshenbaum,et al. Suppression of Akt Signaling Induces Fas Ligand Expression: Involvement of Caspase and Jun Kinase Activation in Akt-Mediated Fas Ligand Regulation , 2002, Molecular and Cellular Biology.
[41] J. Ross,et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[42] A. Goldberg,et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] P. Kang,et al. The Insulin-like Growth Factor 1 Receptor Induces Physiological Heart Growth via the Phosphoinositide 3-Kinase(p110α) Pathway* , 2004, Journal of Biological Chemistry.
[44] J. Woodgett,et al. Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy , 2000, The Journal of cell biology.
[45] A. Goldberg,et al. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.
[46] C. Kahn,et al. Akt Signaling Mediates Postnatal Heart Growth in Response to Insulin and Nutritional Status* , 2002, The Journal of Biological Chemistry.
[47] Luigi Fratta,et al. Melusin, a muscle-specific integrin β1–interacting protein, is required to prevent cardiac failure in response to chronic pressure overload , 2003, Nature Medicine.
[48] P. Sugden. Ras, Akt, and Mechanotransduction in the Cardiac Myocyte , 2003, Circulation research.
[49] S. Elledge,et al. Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex , 2002, Nature.
[50] Y. Ahn,et al. Nuclear Targeting of Akt Enhances Kinase Activity and Survival of Cardiomyocytes , 2003, Circulation research.
[51] A. Mahfoudi,et al. p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. , 1997, Genes & development.
[52] A. Clerk,et al. Regulation of cardiac myocyte protein synthesis through phosphatidylinositol 3' kinase and protein kinase B. , 2001, Advances in enzyme regulation.
[53] N. Takahashi,et al. Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. , 1995, The Journal of clinical investigation.
[54] L. Velloso,et al. Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart. , 1995, The Biochemical journal.
[55] P. Kang,et al. Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice , 2002, Molecular and Cellular Biology.
[56] J. Molkentin,et al. Calcineurin and cardiac hypertrophy: Where have we been? Where are we going? , 2002, The Journal of physiology.
[57] S. Houser,et al. Regression of cellular hypertrophy after left ventricular assist device support. , 1998, Circulation.